Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.31 USD | +0.77% | +0.77% | -24.19% |
09/05 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
09/05 | Transcript : Embecta Corp., Q2 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.19% | 82Cr | |
-5.18% | 18TCr | |
+3.76% | 11TCr | |
-3.32% | 6.84TCr | |
+6.22% | 5.25TCr | |
+8.02% | 4.42TCr | |
+7.52% | 4.35TCr | |
+25.42% | 3.27TCr | |
+17.85% | 2.67TCr | |
-0.45% | 2.58TCr |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Morgan Stanley Adjusts Price Target on Embecta to $31 From $33, Maintains Equal-Weight Rating